Transactions


Year

 

Transaction

 

07/2017
Trinean
Sale of the company to Thermo Fisher Scientific Inc.
Unchained Labs
06/2017
Trinean
Sale of the company to Unchained Labs
Unchained Labs
06/2017
LabConnect
Exclusive placement agent for LabConnect, Inc.
01/2017
Rubicon Genomics
Sale of the company to Takara Bio Inc.
Takara
11/2016
MTI-GlobalStem
Sale of the company to Thermo Fisher Scientific Inc.
Thermo Fisher Scientific
10/2016
maravai LifeSciences
Strategic acquisition of TriLink Biotechnologies.
TriLink Biotechnologies
10/2016
maravai LifeSciences
Strategic acquisition of Cygnus.
Cygnus Technologies
07/2016
BIOO Scientific
Sale of the company to PerkinElmer, Inc.
PerkinElmer
07/2016
Clarity Medical Systems
Clarity Medical Systems has sold its RetCam Ophthalmic
Imaging System business to Natus Medical.
Natus Medical
03/2016
Pathology, Inc.
Sale of the company to Laboratory Corporation of America.
LabCorp
03/2016
Maravai LifeSciences
Strategic equity investment in Vector Laboratories, Inc.
Vector Laboratories, Inc.
07/2015
Sale of the company to OpGen, Inc.
09/2014
Sale of the iPS Cell Business Unit of Stemgent
to ReproCELL, Inc.
08/2014
Sale of miRInform Thyroid™ and Pancreas Test
to PDI Inc.
07/2014
Sale of company to StoneCalibre.
03/2014
Equity investment and strategic collaboration with
Brooks Automation, Inc.
02/2014
Sale of in-vivo preclinical services business to
BIOQUAL, Inc.
08/2013
Sale of sequencing services business to
BioReference Laboratories, Inc.
07/2013
Sale of the Life Science business of SDIX to
OriGene Technologies, Inc.
04/2013
Sale of UVP LLC to Analytik Jena AG.
12/2012
Sale of BioServices business to
Precision Bioservices.
10/2012
Sale of Food Safety and GMO businesses
to Romer Labs.
09/2012
Sale of preclinical in-vivo imaging business to Bruker.
03/2012
Exclusive placement agent for OpGen, Inc.
12/2011
BroadOak Partners provided financial advisory
services to Quanta Biosciences.
09/2011
Non-exclusive license agreement with QIAGEN.
09/2011
BroadOak retained to provide ongoing financial
advisory services.
09/2010
SVT gains exclusive rights in China to ENMD-2076 through
an investment in EntreMed, Inc.
07/2010
Replacement and expansion of Cayman Chemical
Company’s debt facilities.
06/2010
Acquisition of Hyaluron, Inc.
04/2010
Acquisition of GlobalStem, Inc.
12/2009
Sale of in-vivo preclinical CRO services business to
Taconic Farms, Inc.
10/2009
Sale of Alpha Innotech Corp. to Cell Biosciences, Inc.
10/2009
Collaboration and license agreement with Novartis.
08/2009
Sale of non-core assets to Intrexon Corporation.
03/2009
Sale of Assay Designs, Inc. to Enzo Biochem, Inc.
10/2008
Sale of Semrock Inc. to IDEX Corp.
04/2008
Acquisition of biodefense vaccines business from
Avecia Biologics Limited.
06/2007
Sale of Fluorescent Detection Products Business.
View more